Qili Zhang
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Qili Zhang has a total of 15 co-authors. Here are the top co-authors by number of shared publications:
- Yanfang Zhao
Institute of Biomedical Research, Shandong Provincial Research Center for Bioinformatic Engineering and Technique, Zibo Key Laboratory of New Drug Development of Neurodegenerative diseases, School for Life Science, Shandong University of Technology, Zibo, China
3 shared publications - Yujin Gu
School of Life Sciences and Medicine, Shandong University of Technology, Xincun West Road 266, Zhang Dian District, Zibo 255000, China
3 shared publications - Qun Niu
Institute of Shandong Xinhua Pharmaceutical Co., Ltd., Zibo, China
2 shared publications Yanfang Zhao
School of Life Science and Medicine, Shandong University of Technology, Zi bo, China
2 shared publicationsChen Pang
School of Life Sciences and Medicine, Shandong University of Technology, Zibo, Shandong, 255000, China
1 shared publicationHongfang Ji
College of Life Sciences, Shandong University of Technology, Zibo, Shandong 255000, China
1 shared publication
Latest Publications
- Open Access
- 28 October 2024
- Published by Elsevier in Journal of Pharmaceutical Analysis
- Vol. 15 (5) , 101131
The biological roles of exosome-encapsulated traditional Chinese medicine monomers in neuronal disorders
- 28 October 2024
- Published by Elsevier in Journal of Pharmaceutical Analysis
- Vol. 15 (5) , 101131
Open AccessThe biological roles of exosome-encapsulated traditional Chinese medicine monomers in neuronal disorders
- Open Access
Ameliorative Effects of Curcumin on Type 2 Diabetes Mellitus
Type 2 diabetes mellitus (T2DM), a multifactorial and complicated metabolic disorder, is a growing public health problem. Numerous studies have indicated that bioactive compounds from herbal medicine have beneficial effects on T2DM prevention and treatment, owing to their numerous biological properties. Curcumin, the major curcuminoid of turmeric, is one of the most studied bioactive components of herbal supplements, and has a variety of biological activities. Clinical trials and preclinical research have recently produced compelling data to demonstrate the crucial functions of curcumin against T2DM via several routes. Accordingly, this review systematically summarizes the antidiabetic activity of curcumin, along with various mechanisms. Results showed that effectiveness of curcumin on T2DM is due to it being anti-inflammatory, anti-oxidant, antihyperglycemic, anti-apoptotic, and antihyperlipidemic, among other activities. In light of these results, curcumin may be a promising prevention/treatment choice for T2DM.
Open AccessAmeliorative Effects of Curcumin on Type 2 Diabetes Mellitus
Type 2 diabetes mellitus (T2DM), a multifactorial and complicated metabolic disorder, is a growing public health problem. Numerous studies have indicated that bioactive compounds from herbal medicine have beneficial effects on T2DM prevention and treatment, owing to their numerous biological properties. Curcumin, the major curcuminoid of turmeric, is one of the most studied bioactive components of herbal supplements, and has a variety of biological activities. Clinical trials and preclinical research have recently produced compelling data to demonstrate the crucial functions of curcumin against T2DM via several routes. Accordingly, this review systematically summarizes the antidiabetic activity of curcumin, along with various mechanisms. Results showed that effectiveness of curcumin on T2DM is due to it being anti-inflammatory, anti-oxidant, antihyperglycemic, anti-apoptotic, and antihyperlipidemic, among other activities. In light of these results, curcumin may be a promising prevention/treatment choice for T2DM.
- Open Access
- 29 April 2024
- Published by MDPI AG in Preprints.org
Ameliorative Effects of Curcumin on Type 2 Diabetes Mellitus
Type 2 diabetes mellitus (T2DM), a multifactorial and complicated metabolic disorder, is a growing public health problems. Numerous studies indicated that bioactive compounds from herbal medicine have beneficial effects on T2DM prevention and treatment, owing to their numerous biological properties. Curcumin, the major curcuminoid of turmeric, is one of the most studied bioactive components of herbal supplements, which has a variety of biological activities. Clinical trials and preclinical research have recently produced compelling data to demonstrate the crucial functions of curcumin against T2DM via several routes. Accordingly, this review systematically summarizes the antidiabetic activity of curcumin, along with various mechanisms. Results showed that effectiveness of curcumin on T2DM is due to it being anti-inflammatory, anti-oxidant, anti-hyperglycemic, anti-apoptotic, anti-hyperlipidemia and other activities. In light of these results, curcumin may be a promising prevention/treatment choice for T2DM.
- 29 April 2024
- Published by MDPI AG in Preprints.org
Open AccessAmeliorative Effects of Curcumin on Type 2 Diabetes Mellitus
Type 2 diabetes mellitus (T2DM), a multifactorial and complicated metabolic disorder, is a growing public health problems. Numerous studies indicated that bioactive compounds from herbal medicine have beneficial effects on T2DM prevention and treatment, owing to their numerous biological properties. Curcumin, the major curcuminoid of turmeric, is one of the most studied bioactive components of herbal supplements, which has a variety of biological activities. Clinical trials and preclinical research have recently produced compelling data to demonstrate the crucial functions of curcumin against T2DM via several routes. Accordingly, this review systematically summarizes the antidiabetic activity of curcumin, along with various mechanisms. Results showed that effectiveness of curcumin on T2DM is due to it being anti-inflammatory, anti-oxidant, anti-hyperglycemic, anti-apoptotic, anti-hyperlipidemia and other activities. In light of these results, curcumin may be a promising prevention/treatment choice for T2DM.
- Open Access
- 27 February 2023
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 12 (5) , 1883
The Potential Roles of Exosomes Carrying APP and Tau Cleavage Products in Alzheimer’s Disease
Alzheimer’s disease (AD) is the leading cause of dementia throughout the world. It is characterized by major amyloid plaques and neurofibrillary tangles (NFTs), which are composed of amyloid-β (Aβ) peptide and hyperphosphorylated Tau (p-Tau), respectively. Exosomes, which are secreted by cells, are single-membrane lipid bilayer vesicles found in bodily fluids and they have a diameter of 30–150 nm. Recently, they have been considered as critical carriers and biomarkers in AD, as they facilitate communication between cells and tissues by delivering proteins, lipids, and nucleic acids. This review demonstrates that exosomes are natural nanocontainers that carry APP as well as Tau cleavage products secreted by neuronal cells and that their formation is associated with the endosomal–lysosomal pathway. Moreover, these exosomes can transfer AD pathological molecules and participate in the pathophysiological process of AD; therefore, they have potential diagnostic and therapeutic value for AD and might also provide novel insights for screening and prevention of the disease.
- 27 February 2023
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 12 (5) , 1883
Open AccessThe Potential Roles of Exosomes Carrying APP and Tau Cleavage Products in Alzheimer’s Disease
Alzheimer’s disease (AD) is the leading cause of dementia throughout the world. It is characterized by major amyloid plaques and neurofibrillary tangles (NFTs), which are composed of amyloid-β (Aβ) peptide and hyperphosphorylated Tau (p-Tau), respectively. Exosomes, which are secreted by cells, are single-membrane lipid bilayer vesicles found in bodily fluids and they have a diameter of 30–150 nm. Recently, they have been considered as critical carriers and biomarkers in AD, as they facilitate communication between cells and tissues by delivering proteins, lipids, and nucleic acids. This review demonstrates that exosomes are natural nanocontainers that carry APP as well as Tau cleavage products secreted by neuronal cells and that their formation is associated with the endosomal–lysosomal pathway. Moreover, these exosomes can transfer AD pathological molecules and participate in the pathophysiological process of AD; therefore, they have potential diagnostic and therapeutic value for AD and might also provide novel insights for screening and prevention of the disease.
- 20 July 2022
- Published by Taylor & Francis in Food Reviews International
- Vol. 39 (8) , 5934-5947
An Overview of Lithocarpus polystachyus , with Dihydrochalcones as Natural-Derived Bioactive Compounds
Lithocarpus polystachyus (Wall.) Rehd. (L. polystachyus), a natural resource of herbal tea, has been historically consumed by several ethnic minorities. Modern investigations demonstrated L. polystachyus as a versatile pharmacological agent, with antioxidant, anti-inflammatory, anti-diabetes, anti-tumor, anti-hypertension, anti-obesity, hepatoprotection, and neuroprotection activities, meanwhile, no toxicity. Dihydrochalcones as its major, if not the most abundant, active ingredients, are known for numerous biological properties. Particularly, phloridzin, trilobatin, and phloretin, three prominent members of dihydrochalcones, have attracted attentions as either drug candidates or building blocks in modern drug development. In this review, we’ve brought together an up-to-date researches on the bioactive constituents, pharmacological effects and emerging mechanisms of L. polystachyus. We hope this review will provide a scientific rationale for understanding the health benefits, and if possible, preclinical assessment of novel applications of L. polystachyus.
- 20 July 2022
- Published by Taylor & Francis in Food Reviews International
- Vol. 39 (8) , 5934-5947
An Overview of Lithocarpus polystachyus , with Dihydrochalcones as Natural-Derived Bioactive Compounds
Lithocarpus polystachyus (Wall.) Rehd. (L. polystachyus), a natural resource of herbal tea, has been historically consumed by several ethnic minorities. Modern investigations demonstrated L. polystachyus as a versatile pharmacological agent, with antioxidant, anti-inflammatory, anti-diabetes, anti-tumor, anti-hypertension, anti-obesity, hepatoprotection, and neuroprotection activities, meanwhile, no toxicity. Dihydrochalcones as its major, if not the most abundant, active ingredients, are known for numerous biological properties. Particularly, phloridzin, trilobatin, and phloretin, three prominent members of dihydrochalcones, have attracted attentions as either drug candidates or building blocks in modern drug development. In this review, we’ve brought together an up-to-date researches on the bioactive constituents, pharmacological effects and emerging mechanisms of L. polystachyus. We hope this review will provide a scientific rationale for understanding the health benefits, and if possible, preclinical assessment of novel applications of L. polystachyus.
- Open Access
- 14 October 2020
- Published by Elsevier in Journal of Pharmaceutical Analysis
- Vol. 11 (5) , 555-563
Recent advances in research on vine tea, a potential and functional herbal tea with dihydromyricetin and myricetin as major bioactive compounds
- 14 October 2020
- Published by Elsevier in Journal of Pharmaceutical Analysis
- Vol. 11 (5) , 555-563
Open AccessRecent advances in research on vine tea, a potential and functional herbal tea with dihydromyricetin and myricetin as major bioactive compounds